| scholarly article | Q13442814 |
| P2093 | author name string | Jin Hee Kim | |
| Jae Ho Cho | |||
| Chang-Ok Suh | |||
| Do Hoon Lim | |||
| Hyun-Cheol Kang | |||
| Il Han Kim | |||
| In Ah Kim | |||
| Kwan Ho Cho | |||
| Chul-Kee Park | |||
| Byung Ock Choi | |||
| Tosol Yu | |||
| Yong-Kil Hong | |||
| Woong-Ki Chung | |||
| P2860 | cites work | The 2007 WHO classification of tumours of the central nervous system | Q24685772 |
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| Initial treatment patterns over time for anaplastic oligodendroglial tumors | Q30419123 | ||
| International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors | Q30426724 | ||
| CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. | Q30447832 | ||
| Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. | Q30542081 | ||
| Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group | Q30584392 | ||
| Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. | Q30807440 | ||
| Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features. | Q33186142 | ||
| Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...] | Q33247166 | ||
| Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy. | Q33337146 | ||
| Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial | Q33401179 | ||
| Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial | Q33453675 | ||
| Phase I trial of temozolomide using an extended continuous oral schedule. | Q33503863 | ||
| Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group | Q34059674 | ||
| Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. | Q34446549 | ||
| Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma | Q35800632 | ||
| Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group. | Q36898973 | ||
| Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131 | Q37284303 | ||
| MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. | Q38424507 | ||
| Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas | Q41116515 | ||
| NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide | Q43245397 | ||
| Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected]. | Q43245400 | ||
| Clinical discussion of the management of anaplastic oligodendroglioma/oligoastrocytoma (both codeleted and nondeleted). | Q46588887 | ||
| Successful chemotherapy for recurrent malignant oligodendroglioma | Q48090619 | ||
| Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas | Q48374829 | ||
| Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study | Q48428672 | ||
| Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial | Q48467310 | ||
| Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. | Q48493738 | ||
| Oligoastrocytomas: a clinicopathological study of 52 cases | Q48678815 | ||
| Oligodendrogliomas in the CT/MR-era. | Q55473757 | ||
| Chemotherapy for aggressive or anaplastic high grade oligodendrogliomas and oligoastrocytomas: better than a salvage treatment. | Q55475102 | ||
| Combined treatment modality for anaplastic oligodendroglioma: a phase II study. | Q55476559 | ||
| Radiation and chemotherapy improve outcome in oligodendroglioma. | Q55478811 | ||
| P433 | issue | 3 | |
| P921 | main subject | radiation oncology | Q729267 |
| oligodendroglioma | Q1318384 | ||
| oligoastrocytoma | Q1938668 | ||
| adult oligodendroglioma | Q18555324 | ||
| anaplastic oligodendroglioma | Q84955701 | ||
| P304 | page(s) | 531-539 | |
| P577 | publication date | 2014-11-13 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Pattern of care of anaplastic oligodendroglioma and oligoastrocytoma in a Korean population: the Korean Radiation Oncology Group study 13-12. | |
| P478 | volume | 121 |
| Q40572125 | A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13-12. |
| Q47732901 | Modulated Radiotherapy with Concurrent and Adjuvant Temozolomide for Anaplastic Gliomas: Indian Single-center Data |
| Q53077438 | Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study. |
| Q47829546 | Multiple cerebral gliomas mimicking central nervous system inflammatory demyelinating diseases: A rare case with review of literature. |
| Q33649896 | Oligodendrogliomas in pediatric and adult patients: an outcome-based study from the Surveillance, Epidemiology, and End Result database |
| Q39613243 | Utilization and impact of adjuvant therapy in anaplastic oligodendroglioma: an analysis on 1692 patients. |
Search more.